NeurostimulationDevices Market - Global Industry Insights, Trends, Outlook, and OpportunityAnalysis, 2018-2026
Neurostimulation therapy is usedfor treatment and diagnosis of disorders of the nervous system. It reduceschronic pain associated with conditions such as Parkinson’s disease, epilepsy,nociceptive pain, neuropathic pain, and depression. It helps to improve qualityof life of patients suffering from paralysis, obesity, and severe loss ofsensory organs. A neurostimulation device is a key element used in neuralprosthetics for artificial vision, artificial limbs, and hearing aids. Theyinclude implantable and non-implantable devices which deliver chemical,electrical or other agents that reversibly modify nerve cell activity and braincells. They are surgically inserted into the patient’s organs and are operatedwith the help of thin wires and leads.
Intracranial stimulation,peripheral nerve stimulation (PNS), spinal cord stimulation (SCS), deep brainstimulation, and motor cortex stimulation are among the most widely used neurostimulationdevices. As per data published by the European Brain Council, around 6.3million people across the globe were suffering from Parkinson’s disease in2015, and the number is expected to increase steadily in the near future.Spinal cord stimulation is widely used as a treatment in failed back surgery,pain caused by peripheral neuropathy, pain due to low supply of blood to thelimb, chest pain, urinary incontinence, and occipital neuralgia. Deep brainstimulation is generally used to treat Parkinson-plus syndromes.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/430
Global Neurostimulation DevicesMarket – Dynamics
Factors such as increasingprevalence of Parkinson’s disease is expected to fuel growth ofneurostimulation devices market. According to the Parkinson's Foundation,around 1 million people in the U.S. will suffer from Parkinson's disease by2020. It also reports that around 60,000 Americans are diagnosed withParkinson's disease each year. The Parkinson's Foundation also estimates that1.2 million people in the U.S. are expected to develop Parkinson's disease by2030.
According to the Global Burden ofDisease study in 2018 reports that neurological disorders were leading source of disability around theworld, and the fastest growing of these disorders is Parkinson disease. Thestudy also states that from 1990 to 2015, the number of individuals withParkinson disease globally increased 118% to 6.2 million.
Product recalls are one of therestraining factor of the neurostimulation market. For instance, in November2014 U.S. FDA recalls Medtronics’ external neurostimulator due to enabledcycling feature which allows stimulation output to be toggled on and off basedon the programmed settings and it fails to provide accurate information.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/neurostimulation-devices-market-430
Global Neurostimulation Devices Market– Regional Insights
Europe is the second largestmarket followed by the North America in the global neurostimulation devicesmarket owing to product launches by key players. For instance, in January 2017,Abbott launched the Proclaim DRG neurostimulation System in Europe. The productis designed to deliver dorsal root ganglion (DRG) stimulation to patientssuffering from chronic neuropathic pain.
Asia Pacific is expected towitness significant growth over the forecast period owing to the rising prevalenceof neurological disorders. According to the Alzheimer's disease International,in 2015, 23 million individuals in Asia Pacific had dementia, and the number isexpected to increase to 71 million by 2050.
Global Neurostimulation DevicesMarket: Competitive Landscape
Key players operating in theglobal neurostimulation devices market include Virtual Medical Centre Inc.,Neurosigma, Boston Scientific Corporation, St. Jude Medical Inc. (Abbott), NDIMedical, electroCore LLC, Electro Medics, Endostim Inc., and NeuroPace, Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/430
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
